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Cryopreservation of red blood cells (RBC) is an important method for maintaining an inventory of rare
RBC units and managing special transfusion circumstances. Currently, in a clinical setting, glycerol is used
as cryoprotectant against freezing damage. After thawing and before transfusion, glycerol must however
be removed to avoid intravascular hemolysis, via a complex and time consuming deglycerolization
process which requires specialized equipment. Improved cryopreservation methods using non toxic
agents are required to increase biocompatibility and decrease processing time. Biocompatible cryopro
tectants (e.g. trehalose) were proposed, but their low permeation through RBC membranes limits their
cryoprotection efﬁcacy. Herein, we report for the ﬁrst time a glycerol free cryopreservation approach,
using colloidal bioinspired apatite nanoparticles (NP) as bioactive promoters of RBC cryopreservation
mediated by trehalose. Addition of apatite NP in the medium tremendously increases RBC cryosurvival,
up to 91% (42% improvement compared to a control without NP) which is comparable to FDA approved
cryoprotection protocol employing glycerol. NP concentration and incubation conditions strongly
modulate the NP bioactivity. Complementary experimental and computational analyses of the interac
tion between apatite NP and model lipid bilayers revealed complex events occurring at the NP bilayer
interface. Apatite NP do not cross the bilayer but momentarily modulate its physical status. These
changes affect the membrane behavior, and promote the permeation of trehalose and a model ﬂuo
rescent molecule (FITC). This approach is a new alternative to using toxic glycerol for cells cryopreser
vation, and the identiﬁcation of this enhancing no pore permeation mechanism of apatite NP appears as
an original delivery pathway for cryoprotectant agents and beyond.Materials Department, Jozef
. Stefanic), va.baulin@gmail.
-saarland.de (J.-B. Fleury),1. Introduction
Transfusion of red blood cells (RBC) is essential for patients
necessitating blood supplies [1], in particular after traumas or
surgical procedures, but also in cases of blood related pathologies
such as anemia or leukemia [2]. Viable RBC supplies must be
ensured by blood banks, requiring the setup of cell preservation
methodologies [3,4]. Low temperature approaches allow reaching
high rates of cell preservation [5,6], up to 85e90%; however, cur
rent approved RBC cryopreservation methods require high con
centrations of glycerol as cryoprotective agent (e.g. 40% w/v in
North America) [2]. Glycerol has been studied as cryoprotectant for
RBC cryopreservation for decades and its efﬁcacy as cryoprotectant,
the mechanism of its protecting ability, as well as its effects on cells,
tissues and patients as a whole have been well documented [6e8].
However, because of the toxicity of glycerol, which can generate
side effects such as hemolysis or RBC shape alterations [9], the use
of cryopreserved RBC for transfusion necessitates a complex and
lengthy procedure of deglycerolization prior to the use in patients
[10]. This deglycerolization process requiresmultiple washing steps
where about 15% cells are hemolyzed [6]. Also, published studies
pointed out the adverse changes in RBC morphology after cryo
preservation and deglycerolization [10,11]. Moreover, glycerol res
idues remain inside the cells despite this post treatment (<1% for
North America and <0.8% for Europe) [6], which can provoke
complications in some patients. These considerations prevent the
widespread development of cryoprotective approaches for
providing large quantities of RBC to hospital units in minimal
timescales [4]. Nowadays such approaches are limited to rare blood
types.
Thus, improved cryopreservation methods based on non toxic
cryoprotective additives which would not require long post
processing are needed to optimize RBC preservation and allow
better availability of blood to patients.
Alternative biocompatible cryoprotectants including bio
polymers such as polyvinylalcohol (PVA) [12] or sugars [13e15] like
trehalose have been proposed, but their cryoprotective abilities
remain limited [12] for practical relevance and approval from reg
ulatory commissions (expected survival typically > 80%) [2].
Trehalose is a particularly appealing bio inspired cryoprotectant as
it is well known for its role in protecting cells and organisms against
a variety of stresses, including freezing, desiccation, heat shock,
oxidative and osmotic stresses [16,17]. However, in order to provide
maximum protection, trehalose must be present on both sides of
the cell membrane; yet it has very low permeability to RBC mem
brane under normal conditions [16]. Therefore, research has
focused on methods for delivering trehalose into cells, i.e. via the
use of trehalose loaded liposomes [15], membrane permeable
biopolymers [13], electro permeabilization [18], and chemical
methods [16], but research is still in progress for attaining high cell
recovery after freeze thawing.
So far, there have been no reports on the use of inorganic based
compounds for the delivery of trehalose into cells. Yet, bioactive
and biocompatible inorganics have already been found particularly
useful in various biomedical domains (e.g. nanomedicine, medical
imaging/theranostic, regenerative medicine, etc.) [19,20]. Possible
inorganic compounds for delivery of trehalose to RBC could be
calcium phosphates (CaP), which are known for their excellent
biocompatibility, biodegradability and bioactivity [21e24]. More
over, it was demonstrated that biomimetic (bone like) apatite
nanoparticles (NP), which possess structural and chemical simi
larity with the mineral component of bones and dentin [25], are
particularly efﬁcient carriers of drugs and nucleic acids into various
types of cells, making them a promising candidate for further in
vestigations as nanocarriers of payloads in cells [22,26e29]. The
proposed mechanism of apatite NP assisted delivery of bioactive
molecules in cells is generally based on endocytosis mediated
transport. However, endocytosis does not exist in mature
mammal RBC [30], meaning that delivery of trehalose into RBC
assisted by apatite nanoparticles should occur via a different
mechanism, for example via a local modiﬁcation of RBC membrane
physical properties. The nano size and charge distribution of
apatite particles maymodulate their interactionwith RBC cells [31],
although this was reported so far only for the speciﬁc case of
heparin coated hydroxyapatite, in another scientiﬁc context, and in
the absence of cryoprotectants. To date the possibility to useapatite NP for enhancing RBC survival has not been investigated.
Previous work has shown that apatite nanoparticles could be
formulated as colloidal suspensions via the formation of an external
organic corona surrounding the particles. 2 aminoethylphosphate
(AEP) as well as phosphonated polyethyleneglycol have been
shown to be efﬁcient stabilizing agents to form individualized
colloidal apatite NP [23,28]. In the case of AEP stabilized apatite NP,
positively charged particles are obtained due to the presence of an
amino group on the AEP molecule; however the addition of hex
ametaphosphate (HMP) anions was found to improve signiﬁcantly
the dispersibility of the particles, facilitate their puriﬁcation (e.g.
via dialysis process) and favor colloidal stability [22,32]. This effect
can be explained by the organization of HMP anions around the
AEP stabilized particles, thus leading to the formation of a double
layer (positive/negative) organic corona on the surface of apatite NP
as illustrated in Fig. 1a.
Because of this peculiar distribution of positive and negative
charges around the particles, AEP/HMP stabilized apatite NP might
lead to speciﬁc interactions with cell membranes, possibly modu
latingmomentarily the properties of themembrane, which could in
turn promote the permeation of trehalose (see general concept on
Fig. 1b). Based on this hypothesis, and taking into account good
hemocompatibility of colloidal apatite NP [33], the aim of the
present work was to investigate, for the ﬁrst time, the possibility of
using AEP/HMP stabilized colloidal apatite nanoparticles for facil
itating the delivery of trehalose into RBC, in view of promoting their
cryopreservation without the use of glycerol. This paper reports
experimental data on the role of colloidal apatite NP on RBC
viability after freeze thawing cycle and explores, at the molecular
scale and by using synthetic lipid bilayers, the mechanism of in
teractions between RBC and apatite NP. These experiments were
completed by the use of computational methods, with the aim to
explain our experimental observations. The set of complementary
data is presented and discussed, to demonstrate the active role of
colloidal apatite NP for RBC cryopreservation.
2. Results
2.1. Characterization of the colloidal apatite nanoparticles used in
this work
After preparation, the AEP/HMP stabilized colloidal nano
particles (NP) prepared (see Materials and Methods section) were
characterized from a physico chemical viewpoint using comple
mentary techniques. DLS measurements indicated that the mean
NP size followed a monomodal distribution centered on d50 ~
40 nm (Fig. 2a), with d10 ~ 22 nm and d90 ~ 80 nm.
Zeta potential measurements systematically showed an overall
negative surface potential of the order of 50 to 55 mV. This can
be explained by the exposure of HMP anions organized on the
organic corona at the periphery of the particles, and covering the
positively charged AEP adsorbed molecules (Fig. 1a) [22]. XRD an
alyses pointed out the apatitic nature of the particles by compari
son to reference data [25,34], and no additional crystalline
compound was detected indicating that the samples are single
phased (Fig. 3a). FTIR results corroborated XRD conclusions by
the presence of characteristic phosphate vibration modes related to
calcium phosphate apatite (Fig. 3b) [35]. The clear detection
(Fig. 3c) of HPO42 vibrational contributions in the region 530
550 cm1 (as well as at ~ 875 cm1), as in bone mineral [25], along
with the limited contribution of OH ions at 632 cm1 are indica
tive of the nonstoichiometric character of the apatite phase [25],
pointing to the bio inspired nature of these particles. A low degree
of carbonation (arising from atmospheric CO2) may also be detected
in the region 1400 1600 cm1, corresponding to ~ 1 wt. % carbonate
Fig. 1. Schematic description of a) aqueous colloidal suspension ❶ and colloidal AEP/HMP-stabilized apatite nanoparticle ❷, and b) of general concept of enhanced trehalose
permeation into red blood cells (RBC) assisted by colloidal apatite nanoparticles.content (a larger degree of carbonation as in mature bone was not
selected here for not complexifying the system). The presence of
organic groups arising from the presence of adsorbed AEP was
evidenced on FTIR spectra, especially with a band at 754 cm1
characteristic of the Ca2þ(surface)/AEP interaction (Fig. 3b) [28]. The
amount of AEP adsorbed on the NP was measured and corre
sponded to an AEP/apatite molar ratio of ~0.8%. The HMP added to
the colloid represented, on the other hand, an HMP/apatite molar
ratio of ~1.4%. The chemical composition of the (nonstoichiometric)
apatite phase in the NP was found, from calcium and phosphate
titrations and carbonation evaluation, to approach the overall for
mula Ca8.5(PO4)4.5(HPO4)1.4(CO3)0.1(OH)0.5, which as expected de
parts from the composition of stoichiometric hydroxyapatite and is
in contrast close to that of bone mineral [36], thus stressing again
the bio inspired character of this phase. TEM observations of theFig. 2. AEP/HMP-stabilized apatite colloidal NP: a) particle size distributiocolloidal NP were in good accordance with DLS data, showing
ellipsoidal like nanoparticles with a length typically around 40 nm
and a width of about 10 nm (Fig. 2b).
It may be noted that similar results were found for Eu free and
for Eu doped apatite samples (where the experimental Eu/
(Ca þ Eu) molar ratio reached 2.0%).
2.2. Hemolysis of RBC in different incubation media
Incubation of RBC in different incubation media (compositions
reported in Table 1) resulted in rather similar levels of hemolysis, in
all cases lower than 8% (Table 2). Incubation with apatite NP at pH
6.5 and 7.4 for 7 h resulted in the hemolysis of 7.8 ± 1.2% and
6.1 ± 1.4%, respectively. Although these values are slightly higher
compared to RBC in trehalose alone (without NP, 5.6 ± 1.9%) or inn (hydrodynamic diameters from DLS data) and b) TEM micrograph.
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Fig. 3. Complementary analyses of apatite NP used in this work a) XRD pattern, b) FTIR spectrum and c) zoom in the v.(P04) domain . 
làble 1 
Composition of the different incubation media used in this work. 
Incubation media NaCI Trehalose "Apa6S" Apatite NP pH6S "Apa7.4" Apatite NP pH7.4 
c(NaCI) 0.9 wt .% c(NaCI) OSwt.% c(NaCI) os wt.% c(NaO) os wt .% 
c(Hepes) 20mM c (Hepes) 20mM c (Hepes) 20mM c (Hepes) 20mM 
c (trehalose) 0.35 M c (trehalose) 0.35 M c (trehalose) 0.35 M 
c(Apatite) 225 mg/ml c (Apatite) 2.25mg/mL 
pH 7.4 7.4 (or 65 when mentioned) 65 7.4 
Osmolarity (mOsm /L) 320 600 
70 
- 60
600 600 
� Apatite NP 6.5 + trehalose 
[Ilil] Apatite NP 7.4 + trehatose 
- Trehalose atone (pH 6.5) physiological 0.9% NaCI ( 4.4 ± 1.1 %), the limited degree of hemolysis 
observed in ail cases indicates a good biocompatibility relatively to 
BRC, which is in agreement with previous data on hemocompati 
bility of such apatite particles [33 ]. � 
E 50-
40 8 
a.> 
30 
20 a.> 
!lm Trehalose atone (pH 7.4) 
- 0.9% NaCI (pH 7.4) 23. Quantification of intracel/ular trehalose and cryosurvival of
RBC after freeze thawing cycle
The ability for the apatite NP to favor trehalose permeation into 
live RBC was investigated using a trehalose quantification kit. The 
results obtained (Fig. 4) clearly point out the increase of intracel 
lular trehalose when apatite NP are present in the incubation làble 2 
Hemolysis of RBC during incubation in different incubation media (see composition 
in Table 1) for 7 h. 
Incubation media Hemolysis (%) S0(%) 
Apa 6. 5 7.8 12 
Apa7.4 6. 1 1.4 
Trehalose (pH 7.4) 5.6 1 .9 
NaCI 0.9% 4 .4 1.1 
10 
0 
Fig. 4. lntracellular trehalose concentration for RBC incubated in different incubation 
media . Data were derived from three repticates and error bars represent standard 
deviations . 
medium. ln contrast, significantly lower amounts are measured for 
media containing only trehalose or only NaCI. Noteworthy, a 
decrease of the inrubation pH from 7.4 to 6.5 appears to have a clear 
enhancing effect on trehalose permeation when apatite NP are 
present (from 31.3 ± 9.1 up to 50.9 ± 11.7 mM trehalose, respec 
tively), In contrast, no enhanœment is observed for trehalose only 
(about 15 mM trehalose), therefore further experiments run in 
trehalose only medium were conducted, for simplification, at 
physiological pH. 
To investigate the direct impact of apatite NP on RBC cry 
oprotection efficacy, the post freeze thaw survival of cells incu 
bated in trehalose atone was then compared to the survival of ce lis 
incubated in both trehalose and apatite NP (media Apa6.5 and 
Apa7.4, see compositions on Table 1 ). ln particular, survival of RBC 
suspended in Apa6.5 was shown to be dramatically improved 
compared to other incubation media tested (Fig. 5). Incubation in 
Apa6.5 indeed resulted in survival of 90.7 ± 9.8% white survival of 
51.8 ± 6.7% was achieved when RBC were inrubated in trehalose 
atone (Fig. 5). This represents an increase in post thaw viability of 
about 42%. ln contrast, cryosurvival of RBC suspended in Apa7.4 
(58.2 ± 10.1%) was only slightly larger than that of trehalose atone, 
suggesting that medium pH plays a crucial rote in tailoring the 
bioactivity of apatite NP in terms of RBC ciyopreservation. Survival 
of RBC suspended in NaCI 0.9% atone only reached 3.3 ± 1.7% 
(Fig. 5). 
2.4. Formation of a free standing lipid bi/ayer in the presenœ of 
apatite NP 
Within a microfluidic device and using a variant of the Droplet 
Bitayer Technique (see experimental section) [37,38], the formation 
of a free standing lipid bilayer of monoolein or DOPC via a zipping 
process was investigated in the presence of increasing concentra 
tions of NP ( at pH 6.5 or 7.4 ). To this aim, the NP were dispersed in 
two fingers separated by the continuous oity phase (Fig. 6a). 
Supplementary data related to this article can be found online at 
http: / /dx.doi.org/10.1016/j.biomaterials2017.06.018. 
Combining simultaneous optical microscopy and electrophysi 
ological measurements (using a patch clamp amplifier), our ob 
servations indicated that when the concentration of nanoparticles 
was greater than c - 4-5 mg/ml (for both pH values), no bilayer 
could be produced (as evidenced from optical and electrophysio 
logical measurements). ln contrast, for lower NP concentrations in 100 
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Fig. 5. RBC survival after freeze-thawing in different media (RBC were incubated in 
media for 7 h at 37 •c prior to freezingi the range of 3 to 0.1 mg/ml, a stable lipid bitayer was obtained, as 
indicated by measure of the bitayer specific electrical capacitance Cs 
(see Supporting Information, Fig. S1 ). The capacitance signal how 
ever revealed the presence of strong fluctuations just before 
achieving the bitayer formation: these fluctuations likely resulted 
from perturbations due to the adhesive interaction between the NP 
and lipid molecules. These findings already point out the existence 
of a non negligible interaction between the hydrophitic apatite NP 
and the lipid membrane. 2.5. Interaction ene'ID' between apatite NP and s ynthetic lipid 
bi/ayers 
A recently developed method enables extraction of the average 
free energy of adsorption [39], by using electrophysiological mea 
surements. The method estimates the surface coverage with NP 
from the change in the magnitude of the electrical capacitance ( Cs) 
plateau as a function of the NP concentration [37]. The lipid bitayer 
surface coverage can then be plotted as a function of the NP con 
centration (Fig. 6c): the plots present the shape of a Langmuir 
isotherm adsorption, assuming a dynamic equilibrium between the 
free NP in solution and the NP adsorbed to the model membrane. ln 
this model, the surface is considered to have a spedfic number of 
sites where the NP can adsorb, and these sites are ail equally active, 
giving rise to a single average value of equilibrium constant KL, The 
Langmuir equation gives the relationship between the surface 
coverage fJ and NP concentration c: 
8 (1) 
After obtaining KL, it becomes possible to estimate the corre 
sponding standard free energy for the adsorption of apatite NP to 
the surface of the lipid bitayer by the following equation: 
RTln(Ki) (2) 
where R is the gas constant (8.314 J K-1 mo1-1) and Tthe absolu te
temperature (in Kelvin). 
Following this procedure for the two different media Apa6.5 and 
Apa7.4, we measured different NP adsorption behaviors depending 
on the pH value (Table 3). 
Results pointed out a larger adsorptive interaction at pH 6.5 
compared to pH 7.4, as can be seen on Fig. Sc and from the .i::IC° 
values estimated in Table 3. lt may be noted that experiments run 
with Eu doped apatite NP led to veiy similar results, within 5% of 
variation. These results suggest a greater degree of interaction be 
tween the NP (whether doped or not with europium) and the lipid 
bilayer at slightly addic pH rather than at physiological value. The 
order of magnitude of .i::IG0, close to 30 kj moi-1, points to a sit
uation intermediate between physisorption and chemisorption 
[ 40,41 ], indicating a non negligible degree of interaction. 2.6. Translocation of Eu doped apatite NP through the lipid bi/ayer 
Translocation of fluorescent Eu doped apatite NP through the 
lipid bitayer was followed using a two droplets system (see detaits 
in experimental section). One droplet (left on Fig. 6b) was 
composed of a medium containing Eu doped apatite NP ( e.g. 0.1 ng/ 
ml), white the second droplet (right on Fig. 6b) was composed of 
the same medium but without NP. Observation via fluorescence 
microscopy indicated that the NP, animated by Brownian motion 
and sometimes interacting with the membrane, systematically 
remained on the initial compartment (independently of the NP 
concentration tested) and were not able to passively cross the 
Fig. 6. a) Sketch of the microﬂuidic cross-channel geometry, displaying two ﬂui rs (aqueous phase in blue) and the oily continuous phase (orange arrow, ﬂuid not shown).b)
Epiﬂuorescence micrograph of ﬂuorescing Eu-doped apatite NP next to lipid bilayer (see Video 1 in Supporting Information).c)Langmuir isotherms describing the bilayer coverage as
function the NP concentration (for two different pH values of the buffer) determined from bilayer capacitance measurements.d) Micrographs of two water droplets with their
interfaces separated by a DOPC lipid bilayer (also see Video 2 in Supporting Information). At the start of the experiment (time 0 s) the right droplet is full of ﬂuorescent FITC and
apatite NP, while the left droplet is just ﬁlled with buffer. This image taken at 640 s shows a transfer of FITC from the right droplet to the left droplet in the presence of apatite NP. In
the absence of apatite NP, FITC does not diffuse to the left droplet (see Video 3 in Supporting Information). (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
Table 3
Calculated values of equilibrium constant (Langmuir) KL for the system NP/bilayer
and related values of the standard free energy of interaction DG .
pH KL (L mol 1) DG (kJ mol 1)
DOPC (medium Apa6.5) 6.5 4 $ 105 32.0
DOPC (medium Apa7.4) 7.4 1.5 $ 105 29.5bilayer (see also Video 1 in Supporting Information). Even for ex
periments performed at high NP concentrations (c ~ 1 mg/mL), no
particle translocation event was observed even after 8 h of optical
observation; and this result was obtained for the 3 pure lipid
bilayer compositions monoolein, DOPC and DPHPC.2.7. Translocation of FITC through the lipid bilayer
Translocation of ﬂuorescent FITC, used as trehalose substitute,
through lipid membranes was followed using the two droplet
system (Fig. 6d). One droplet (right on Fig. 5d) contained the me
dium (either Apa6.5 or Apa7.4) with NP (e.g. 1 mg/mL) and dis
solved FITC (2 mM), while the second droplet (left on Fig. 6d)
contained the samemedium but without NP and FITC. By observing
both droplets via ﬂuorescencemicroscopy, we could follow the FITC
transfer across the lipid bilayer over time when apatite NP were
present in the medium (see Video 2 in Supporting Information). In
addition, the FITC diffusion rate was found to increase with the NP
concentration (Fig. S2 in Supporting Information). As can be
Fig. 7. Single Chain Mean Field Theory calculation of interaction between an apatite NP
(hydrophilic) and the lipid bilayer. NP attracts the heads of lipids (density of heads is
shown in color: red high volume fraction, blue low volume fraction) and de-
stabilizes the lipid bilayer making it more permeable. The diameter of the tip of NP is
10 nm, the attraction parameter is εH 7 KT . (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to the web version of this article.)observed on Fig. 6d, at the start of the experiment the droplet
containing FITC was bright (due to FITC ﬂuorescence) while the
droplet without FITC remained dark. After few seconds of incuba
tion, a ﬂuorescent front started to propagate into the dark droplet,
and the characteristic shape of a diffusive front emerged in the dark
droplet and propagated over time, indicating the translocation of
FITC over the lipid membrane (Fig. 6d). It is important to note that
FITC translocation was observed only in the presence of apatite NP
(with or without Eu doping) and in both media Apa6.5 and Apa7.4;
in contrast no diffusion, during the ﬁrst 15 min, was noticed
without apatite particles in the medium (Video 3 in Supporting
Information).
Normalizing the brightness in Fig. 6d to the ﬂuorescence signal
of the initial FITC concentration in one of the droplets (i.e. 2 mM),
we could estimate the translocation rate of FITC molecules across a
bilayer to ~0.2 mmol L1 s1 for a monoolein bilayer and to
~0.07 mmol L1 s1 for a DOPC bilayer. The experiments were also
repeated for more complex bilayer composition, leading to trans
location rates of ~0.05 mmol L1 s1 for an asymmetric DOPC/
DPHPC bilayer and of ~0.03 mmol L1 s1 for a “Red Blood Cell like”
composition (see experimental section).
2.8. Computational modeling of the NP/bilayer interaction
The lipid bilayer/apatite nanoparticle interaction was also
studied here from a simulation viewpoint, based on the Single
Chain Mean Field (SCMF) theory [42,43]. The method has indeed
been shown previously to describe adequately the mechanical
properties of lipid bilayers [42]. Using a 3 beads model (one head
bead H and two tail beads T) to describe lipid bilayer with previ
ously reported parameters [42], the bilayer is represented by the
ﬁelds of lipid tails (T) and heads (H), which are allowed to rearrange
due to local environment and interactions with external objects.
Here, the apatite nanoparticle was considered spherical and was
modeled as adsorbing to lipid heads (H) through the negative
interaction parameter εH. This parameter denotes the attraction of
lipid heads H to the surface of the NP. Due to the curvature of the
NP, a strong attraction of lipid heads toward the surface of NP is
generated, leading to the lifting of lipids out of the bilayer plane, as
illustrated in Fig. 7.
These calculations thus suggest that the lipid bilayer is not
broken down but that the NP/lipid interaction however partly
disrupts the upper leaﬂet of the bilayer at the position of contact
between the NP and lipid bilayer. The destabilized bilayer could
then lead to enhanced permeability of low molecular mass com
ponents. This mechanism suggests also that the disruption of the
bilayer is reversible.
3. Discussion
Incubation of RBC with apatite NP both at pH 6.5 and 7.4
(Table 2) resulted in low levels of hemolysis (<8%). Although
slightly larger than for incubation in physiological NaCl solution,
these results indicate that the apatite NP studied here are
biocompatible with regard to RBC and suitable for applications in
blood transfusion. These ﬁndings agree well with recent studies
where the good hemocompatibility of apatite NP was reported,
especially concerning direct contact with RBC [31,33].
The present work was aimed at exploring the possible
enhancing role of AEP/HMP stabilized apatite NP on the cry
osurvival of RBC, especially in link with their peculiar surface
charge distribution. The goal in the present study was to use
colloidal apatite NP since this colloidal state, provided by the sta
bilizing organic corona, ensures the stability of the suspensions and
avoids unwanted post agglomeration. In this study, we employedrelatively rapid freezing and thawing in the cryopreservation pro
tocol; indeed previous works have shown that rapid freezing and
thawing of RBC resulted in signiﬁcantly higher survival rates
compared to slower protocols [13,14,44]. Our results reveal that the
presence of such tailored apatite NP with speciﬁc properties (size,
surface charge) in the incubation medium increased massively the
degree of cryosurvival of RBC in the co presence of trehalose
(Fig. 5). The selection of incubation conditions (pH, ionic strength,
NP concentration) was found to be essential for optimizing the
bioactivity of apatite NP toward RBC cryosurvival. When RBC were
incubated in trehalose apatite medium at pH 6.5 (medium
“Apa6.5”), a survival rate of 91% was reached, which is comparable
to the FDA approved cryopreservation protocol employing glycerol
as a cryoprotectant (survival rate 85e90%) [5].
The role of the medium pH was especially found to be signiﬁ
cant, as incubation at physiological pH (7.4) decreased the cry
osurvival rate from 91 down to about 60%. This pH effect might be
related to a modulation of the afﬁnity of molecular species (here
lipid moieties) for the surface of apatite. An acidiﬁcation from 7.4 to
6.5 was previously reported to lead, in the case of DNA adsorption
on (non colloidal) biomimetic apatite [45], to an increased
adsorption amount, which was tentatively explained by the release
of some HPO42 ions from the apatite surface in acidic conditions, in
turn favoring the adsorption of the ionic backbone of DNA by
providing anchoring surface sites. In the present case, a similar
scenario could come into play as well, between lipid heads and
apatite particles. Hence, this appears to be validated by our
experimental data (Fig. 6c and Table 3), where an increased inter
action was detected between the lipid bilayer and apatite nano
particles at pH 6.5 as compared to pH 7.4, as shown by the
differences in membrane capacitance. This effect of pH does not
seem to be solely linkable to a change in the organic corona as the
observations reported previously on nucleotide or DNA adsorption
enhanced at slightly acidic pH [45] were made on non colloidal,
purely apatitic systems.
Additional evidence of the existence of a strong interaction
between apatite NP and the bilayer was shown by investigating the
possibility to form free standing bilayers in the presence of
increasing concentrations of NP. Indeed, although the zipping
process of the bilayer remained possible for NP concentrations
lower than 3 mg/mL, this process became hindered at high NP
concentrations. This illustrates an interfering effect of the hydro
philic apatite particles on lipid organization, especially detectable
at high NP concentration. An analysis of the capacitance signal
during the bilayer zipping process was also carried out, and
conﬁrmed the formation of stable bilayers below 3 mg/mL of NP
(see Figure S1 in Supporting Information). The presence of ﬂuctu
ations before bilayer stabilization illustrates perturbations linked to
the adhesive interaction between the NP and the lipid molecules.
After bilayer formation and reaching a stable capacitance value, the
corresponding speciﬁc capacitance CS can be measured so as to
follow the effect of the NP. Interestingly, CS increases with the
concentration of apatite NP (Fig. 6c). Theoretically, this increase
could indicate a reduction of the corresponding bilayer thickness as
CS
ε0εL
d (e.g. from 2.7 nm for a monoolein bilayer without NP to
2.3 nm with a NP concentration of 1 mg/mL), where εL is the
dielectric constant of the lipid membrane in the oily phase (squa
lene), εL ~ 2.2 F m1, and ε0 is the vacuum permittivity ε0 ~
8.85.1012 F m1 respectively. Although a bilayer thickness reduc
tion does not appear as a probable conclusion in the present case,
this capacitance reduction is nonetheless a clear consequence of
membrane modiﬁcation, via the adsorption or insertion of charged
nanoparticles into the bilayer. However, these conductivity mea
surements do not allow directly distinguishing between NP
adsorption on the bilayer or partial/complete insertion of NPwithin
the bilayer. In order to examine this point, we performed additional
experiments by repeating capacitance measurements when NP
were dispersed only on one side of the lipid bilayer (with a
concentration ~ 1 mg/mL). During the experiments, a change in the
bilayer capacitance was again observed, but decreased by a factor
1.6 compared to the situation where NP were dispersed on both
sides of the membrane. These observations indicate that apatite NP
do not passively cross the lipid bilayer but rather adsorb on it
without being inserted into the bilayer core.
To further conﬁrm that these NP are not able to translocate
passively through the bilayer, we set up a novel two droplet
methodology where ﬂuorescent europium doped apatite NP were
dispersed on one side of the bilayer while the other side was
composed of the buffer alone. Epiﬂuorescence microscopy analyses
then demonstrated (Fig. 6b) that the NP remained on their initial
compartment even after several hours of incubation (see also Video
1 in Supporting Information), again validating that such NP cannot
passively cross the lipid bilayer.
Our cryosurvival data pointed out however that the presence of
apatite NP beside trehalose allowed a signiﬁcant increase in the
RBC cryosurvival as compared to trehalose alone, thus suggesting
that more trehalose was able to cross the lipid bilayer in the
presence of apatite. Nevertheless, the above results show that
apatite NP themselves are not able to translocate through the
membrane, despite evident local modiﬁcations of the physical/
electrical properties of the bilayer. A hypothesis can then be
formulated concerning the mechanism of action of the NP, along
which these charged NP could facilitate trehalose permeation by
altering locally, reversibly and momentarily the membrane prop
erties, providing transient diffusion pathways for trehalose (see
schematic view of the concept on Fig. 1b).
In order to validate this hypothesis, we investigated the possiblepermeation of FITC (a small ﬂuorescent molecule mimicking
trehalose) through a DOPC lipid bilayer, in the presence or absence
of apatite NP. This set of experiments again used the two droplet
methodology, placing FITC on one side and checking its potential
diffusion over time into the other compartment. Fluorescence mi
croscopy clearly indicated the enhanced diffusion of FITC through
the lipid bilayer in the presence of apatite NP (Fig. 6d and Video 2 in
Supporting Information), and the diffusion rate was found to be
function of the NP concentration (Figure S2 in Supporting
Information). On the contrary, no FITC detection was recorded in
the absence of NP (see Video 3 in Supporting Information). One
criticism of this experimental investigation could be that FITC
molecules are, in some cases, able to cross some DOPC bilayers [46];
however this process would be slower than the one reported here
where a clear activation by apatite NP is detected. Nevertheless, to
rebut this point, we also repeated this experiment with membrane
compositions that are known to be impermeable to FITC, which is
the case for membranes with asymmetric composition like DOPC/
DPHPC. Even in this case, we measured again a clear activated
transfer of FITC as a function of the NP concentration (Figure S2 in
Supporting Information) and attainment of a plateau. These ﬁnd
ings offer a strong experimental demonstration of the enhanced
permeation of FTIC (mimicking trehalose) when incubation is car
ried out in the co presence of our apatite NP.
The increased permeation of FITC (through artiﬁcial lipid bi
layers) and of trehalose (in actual RBC) are likely attributable to the
same type of mechanism. This underlying mechanism is antici
pated to be a consequence of formation of curvatures within the
bilayer structure, which could lead to physical/biochemical changes
in the membrane and allow increased transient permeability. The
possibility of bilayer curvatures without membrane rupture has for
example been reported, in other circumstances [47]. Moreover,
hydroxyapatite nanoparticles (although of different composition)
were shown to elicit formation of membrane curvatures in sus
pensions of RBC [31]. To deepen the examination of this point, we
performed numerical simulations using the SCMF theory, where
lipid molecules were modeled by a 3 beads model (one head bead
H and two tail beads T) and apatite NP by a sphere, in a ﬁrst
approximation, in interaction with the heads of lipids (H). The
launch of the computation evolved toward a local deformation of
the bilayer (Fig. 7). This modeling thus suggests some degree of
local destabilization/curving of the bilayer when apatite NP are
present, which is in perfect agreement with our bilayer capacitance
measurements showing a local alteration of the membrane phys
ical/electrical properties when contacted with the NP (Fig. 6c and
Figure S1 in Supporting Information). The formation of actual
“nanopores” can however be excluded based on our experimental
observations as no pores were detected by electrophysiological
measurements (even at high NP concentration). Only a local
modiﬁcation of the 3D organization of the lipid molecules consti
tuting the membrane is involved.
By momentarily and locally altering the lipid bilayer (in a
reversible way since the bilayer remains experimentally stable over
time), all these results concur to elucidate, both from experimental
and computational viewpoints, the enhanced permeability noticed
for low molecular weight components like trehalose and FITC,
when AEP/HMP colloidal apatite NP are present in the medium,
thus explaining in turn the improved RBC cryosurvival data. As a
ﬁnal conﬁrmation of these conclusions, the intracellular trehalose
was titrated using a trehalose quantiﬁcation kit after a developed
cells lysis/trehalose extraction procedure. As expected (Fig. 4), the
amount of trehalose quantiﬁed for RBC incubated in the presence of
colloidal apatite NP was signiﬁcantly increased as opposed to
trehalose alone, which followed well the cryosurvival data (see
Fig. 5).
4. Conclusion
Incubation of RBC with colloidal bio inspired apatite NP in the
co presence of trehalose is reported here, for the ﬁrst time, to
dramatically increase the cryosurvival of RBC after freeze thawing.
RBC cryosurvival reached 91%, equivalent to the FDA approved
procedure using glycerol. A complementary set of data, based on
experimental and computational results, concurred to show that
AEP/HMP stabilized apatite NP enhance the permeation of treha
lose through the bilayer by locally interacting with the lipid bilayer.
Trehalose translocation into RBC is facilitated via an indirect
mechanism arising from NP/bilayer interactions (and not by the
direct formation of temporary pores in the membrane). Results
suggest that apatite NP enable the translocation of trehalose by
locally modifying the 3D organization of the lipids in the interac
tion with NP, through transient breaching of the lipid bilayer.
To the best of our knowledge, this is the ﬁrst report on the
application of biocompatible inorganic compounds for cryopres
ervation applications. The massively increased survival of RBC after
freeze thawing coupled with the high biocompatibility of colloidal
AEP/HMP stabilized apatite NP and their low cost of production
make such system a relevant alternative to commonly used toxic
preservation agents (DMSO, glycerol), and show great promise for
future applications in the cryopreservation of blood and mammal
cells, and in biomedicine in general.
5. Experimental section
5.1. Preparation and characterization of bio inspired apatite
nanoparticles
Apatite colloidal suspensions were obtained as follows: bio
inspired non stoichiometric nanocrystalline apatite Ca10-x(PO4)6-
x(HPO4,CO3)x(OH)2-x was precipitated at room temperature from
calcium nitrate and di ammonium hydrogenphosphate in deion
izedwater, at pH 9.5, and in the presence of 2 aminoethylphosphate
NH3þeCH2eCH2eOeP(O) (O)2 or “AEP” for agglomeration control;
AEP being a biocompatible molecule encountered naturally in the
composition of cell membranes (AEP represents the polar head of
the phospholipid phosphatidylethanolamine) [48]. The AEP:Ca
molar ratio in the reactingmediumwas set to 1:1. All reactantswere
of reagent grade. Solution A (6.25 mL) contained calcium nitrate
tetrahydrate Ca(NO3)2$4H2O (4.87 mmol), solution B (6.25 mL)
contained AEP (4.87 mmol), and solution C (12.5 mL) contained di
ammoniumhydrogenphosphate (1.62mmol). Solution Awasmixed
with solution B under constant stirring, leading to solution D. The
acidic pH of this resulting solution as well as that of solution C were
adjusted to 9.5 by addition of few drops of concentrated ammonia.
Mixing C and D allowed precipitation. The suspension was then
allowed to mature in an oven preset at 100 C for 16 h. When
mentioned in the text, europium doped apatite suspensions (con
taining luminescent Eu3þ ions as previously reported) [49] were
also prepared by following the same protocol but replacing
1.5 mol.% of calcium nitrate in the starting medium by the same
molar amount of europium (III) nitrate.
Each colloid (25 mL) was then puriﬁed by dialysis as previously
described in detail [50]. Brieﬂy, dialysis was carried out at room
temperature using a tubular cellulose membrane (molecular
weight cut off: 6000e8000 Da) held vertically and introduced in
900 mL of dialysis medium (deionized water) under constant stir
ring. The dialysis mediumwas regularly exchanged with a fresh one
after 4, 8, 22 and 26 h. Sodium hexametaphosphate (NaPO3)6 or
“HMP” was added to the puriﬁed colloids for improving dis
persibility and for lowering the suspension pH down to physio
logical value: addition of HMP was stopped when reaching pH y7.4. Afterwards, the colloids were freeze dried for facilitating stor
age before use. Glucose, a hydrosoluble matrix, was added (15 mM)
to the colloidal NP prior to freeze drying for preventing uncon
trolled aggregation and favoring the NP redispersion in themedium
while preserving particle size distribution [32]. Before the start of
experiments, each freeze dried colloid was reconstituted with
deionized water to reach the ﬁnal NP concentration of 2.25 mg/mL
and ﬁltered through a 0.2 mm syringe ﬁlter.
The apatite NP were characterized using different complemen
tary techniques. Dynamic light scattering and zeta potential mea
surements were performed on a Zetasizer Nano ZS (Malvern
Instruments, l 630 nm) and allowed to determine respectively
the hydrodynamic diameter of the particles (so called “particle
size” in the remaining of the text) and their overall surface charge.
The crystallographic structure of freeze dried particles was inves
tigated by X ray diffraction (XRD) using a CPS 120 INEL diffrac
tometer with the Ka Cobalt radiation (1.78892 Å). Fourier transform
infrared (FTIR) spectroscopy analyses were run on a Nicolet 5700
spectrometer, in the wavenumber range 400e4000 cm1 with a
resolution of 4 cm1. Ca and Eu contents were checked by Induced
Coupled Plasma Atomic Emission Spectroscopy, ICP AES (relative
uncertainty: 3%). The phosphate content was determined by
spectrophotometry (Shimadzu UV 1800) at l 460 nm using the
yellow phospho vanado molybdenum complex (relative uncer
tainty: 0.5%) [51]. The carbonation content was estimated from the
relative integrated band intensities between the n3CO3 and the
n1n3PO4 bands following the methodology previously published
[52]. The AEP content associated to the colloidal nanoparticles was
determined by nitrogen microanalysis (relative uncertainty 0.4%).
Transmission electron microscopy (TEM) was run on a JOEL JEM
1011 set at 100 KeV. For these TEM observations, the suspensions
were brieﬂy sonicated (50 kHz, 30 s) and carbon coated copper
TEM grid were rapidly dipped into the suspension and allowed to
dry prior to analysis.
5.2. Incubation media
Four different incubation media were used in the study
(Table 1). Incubation media with bio inspired apatite NP (Apa6.5,
Apa7.4) were prepared by dissolving NaCl, Hepes and trehalose (D
(þ) trehalose dihydrate) powder in the fresh aqueous suspension
of reconstituted apatite NP suspension (c 2.25 mg/mL). After
wards, the pH of the mediumwas adjusted with NaOH/HCl using a
digital pH meter (FE20, Mettler Toledo, Switzerland). All chemicals
were purchased from Sigma Aldrich, UK. In the study, the con
centration of trehalose was determined to have relatively high
concentration of trehalose but still in the range that would not
provoke hemolysis due to osmolarity excess. In this context, 0.35 M
trehalose and total osmolarity of 600 mOsm were selected as
relevant conditions in these incubation experiments. The apatite
NP concentration was ﬁxed to 2.25 mg/mg so as to remain lower
than the 3 mg/mL limit noticed during bilayer formation in our
model system (free standing lipid bilayers). The pH values used in
this work (6.5 and 7.4) were selected so as to have enough differ
ence between the two values to get evidence of possible modiﬁ
cations while avoiding too acidic conditions being detrimental to
non stoichiometric apatites (partial dissolution) and to RBC (po
tential hemolysis).
5.3. Preparation of RBC
RBC were isolated from the fresh whole sheep blood supplied in
Alsever's medium (TCS Biosciences Ltd, UK) and used within two
days. Before use, RBC were washed with physiological 0.9% NaCl
solution (Table 1), centrifuged (at 600 g for 15 min) and then the
supernatant was discarded. Two more NaCl washes were per
formed before use.
5.4. Loading of RBC with trehalose
Washed RBC were divided into 0.5 mL samples of approximately
10% packed cell volume (hematocrit) and centrifuged at 600 g for
2 min. Their supernatants were discarded and 0.45 mL of incuba
tion medium (Table 1) was added to yield a ﬁnal RBC concentration
of approximately 10% hematocrit, or approximately 3.108 RBC mL1.
Resulting mixtures were homogenously re suspended and incu
bated in an air bath incubator (Binder UK; Wolverhampton, UK) for
7 h at 37 C and slowly rotated (Maplelab Scientiﬁc Ltd, UK) at
10 rpm. The incubation duration of 7 h was selected here on the
basis of previous studies by Lynch and Slater et al. on the cryo
preservation of RBC and intracellular delivery of trehalose [53e55].
Cell count was performed both at the start and at the end of in
cubation using a hemocytometer (Hawksley, UK).
5.5. Quantiﬁcation of intracellular trehalose
An experimental procedure was set up here to allow the
quantiﬁcation of intracellular trehalose. This procedure involved
several successive steps: 1) Incubation of RBC in incubation media
(Table 1) for 7 h (for trehalose alone, both pH values 6.5 and 7.4
were here tested); 2) After gentle centrifugation (i.e. 250 rpm) the
trehalose rich supernatant was discarded and the remaining cell
pellet was washed with large volume of cold NaCl iso osmotic to
the incubation medium (~600 mOsm) to remove extracellular
trehalose. The suspension was centrifuged again and the NaCl su
pernatant was discarded. The obtained cell suspensionwas used for
quantiﬁcation of trehalose. 3) 300 mm3 of deionized water were
added to the RBC pellet to lyse the cells and then mixed with 5 mL
80% methanol for trehalose extraction. The mixture was incubated
in the ultrasound bath at 80 C for 2 h under constant sonication.
Samples were then centrifuged at 3000 g for 10 min and the
methanol supernatants were collected separately in tubes. These
supernatants were then evaporated in an oven set at 80 C over
night to leave dry trehalose residues in tubes. This procedure, from
methanol addition to evaporation, was then repeated one more
time. After ﬁnal evaporation, the tubes with trehalose residues
were kept in a freezer until further analysis. 4) For the quantiﬁca
tion of trehalose, 600mm3 of milli Q water were added to the tubes
with dry trehalose residues. The tubes were then vortexed/soni
cated several times at elevated temperature (~50 C) for ~ 30min to
ensure that all trehalose was dissolved. Trehalose content was then
quantiﬁed using the trehalose assay kit (Megazyme, USA) according
to manufacturer instructions and by using the microplate assay
procedure (Synergy H1, USA). To ensure that reported values are
only due to intracellular trehalose, negative controls were put in
place. Incubating RBC in corresponding incubation media for
~1 min and then passing them through the trehalose measurement
protocol allowed determination of the amount of measured
trehalose due to extracellular trehalose incompletely removed
during washing. The negative controls were used for each incuba
tion media and all reported loading values are relative to their
corresponding negative control values. Intracellular concentration
of trehalose was calculated according to the following equation:
C
nðtrehaloseÞ
VðintracellularÞ
nðtrehaloseÞ
MCV $N $v
(3)
where C [mM] is the concentration of intracellular trehalose,
n(trehalose) [moles] is the measured amount of trehalose and
V(intracellular) is the total intracellular volume in a sample that isoccupied by water and available to trehalose and other solutes.
n(trehalose) was determined by multiplying the measured con
centration of trehalose by the volume of water added in the tube
(600 mm3). V(intracellular) was calculated for each sample by
multiplying the number of RBC contained in the suspension
(concentration ~ 2.5  109 cells mL1) by the mean cell volume
(MCV) of RBC in the incubation medium (~30  1015 L). The value
was multiplied by 0.7 to account for the fact that only 70% of the
intracellular RBC volume is accessible to water, as the remaining
30% is occupied by membranes [56]. MCV of RBC incubated in
different media has been measured via microhematocrit. After in
cubation period, RBC suspensions with known cell concentration
were centrifuged in 70 mm microhematocrit tubes at 6000 g
(Domel Centric 150, Slovenia) for 10 min according to the manu
facturer's instructions and then packed cell volume (hematocrit)
was determined. MCV was then calculated by dividing the hemat
ocrit with the cell concentration. The calculated MCV of RBC in
different media were as follows: 3.2  1014 L (medium “0,9%
NaCl”); 3.0  1014 L (media “Apa6.5” and “Trehalose pH 6.5”);
2.5  1014 L (media “Apa7.4” and “Trehalose pH 7,4”).5.6. Hemolysis assay
Hemolysis of RBC after incubation in the different media
(Table 2) was evaluated by measuring hemoglobin absorbance at
541 nm using a spectrophotometer (SP75, Sanyo, Japan). The
Drabkin's method for hemoglobin assay was not employed because
methemoglobin concentration was insigniﬁcant after incubation at
all steps of trehalose loading (data not shown) [13]. Washed RBC
were used to create a calibration curve relating RBC mL1, counted
using a hemocytometer (Hawksley, UK), to hemoglobin absorbance
after the lysis of those cells. Initial cell count (cell count of samples
before incubation or freezing and thawing) was evaluated by lysing
control samples with deionized water via hypotonic osmotic shock
and measuring hemoglobin absorbance. The number of cells that
lysed during experimentation was evaluated by centrifuging sam
ples after experimentation and measuring the hemoglobin absor
bance of the supernatant. Percent hemolysis was then calculated as
follows:
hemolysisð%Þ 100$lysed cell count after incubation
initial cell count
(4)5.7. RBC cryosurvival evaluation
RBC were incubated at approximately 10% hematocrit in either
0.9% NaCl, 0.35 M trehalose or 0.35 M trehalose þ apatite NP (pH
6.5 and 7.4), each for 7 h at 37 C. The complete compositions of the
different media used in this study are listed in Table 1. In addition to
Hepes, glucose is present due to the redispersion of freeze dried
apatite NP. The cryopreservation protocol utilized relatively rapid
freezing and thawing: freezing was accomplished by direct im
mersion of samples in liquid nitrogen as described [13], a method
similar to the one with a freezing rate that has been estimated at
265 ± 12 C min1 [15]. After immersion in liquid nitrogen samples
were transferred to a freezer at 80 C for a minimum one day.
Thawing was accomplished by warming samples in a 37 C water
bath. After thawing, cell number in suspensions was determined
using a hemocytometer. Percent survival of RBC after cryopreser
vation was calculated based on normalization to pre freeze cell
number:
cryosurvival ð%Þ 100$cell count after freezing and thawing
cell count after incubation
(5)5.8. Study of interaction between apatite NP and model membranes
in a microﬂuidic device
A microﬂuidic device was used to study the mechanism of
interaction between apatite NP (possibly doped with europium)
and model lipid membranes, and to follow the possible trans
location of Eu doped apatite and of a ﬂuorescent trehalose substi
tute (FITC) through the membrane barrier. FITC is a hydrophilic
membrane impermeable organic dye with similar molecular
weight as trehalose, and was used as a ﬂuorescent tracer and
trehalose substitute to study molecular translocation through the
membrane barrier. The device consists of a cross geometry made of
micro channels with rectangular cross section fabricated by soft
lithography (5a). Channel dimensions were 200e300 mm in width
and 140 mm in height. The device was molded against a SU 8 photo
resist master on a silicon wafer using poly(dimethylsiloxane)
(PDMS) (Sylgard 184, Dow Corning, USA). The surface of the PDMS
devices was exposed to plasma (Diener electronic GmbH, Germany)
and sealed with a plasma treated glass cover slide. The sealed de
vice was rendered hydrophilic by heating to 135 C overnight. The
liquids were dispensed from syringes (Hamilton Bonaduz AG,
Switzerland) connected to the microﬂuidic device via Teﬂon tubing.
A homemade computer operated syringe pump was used to con
trol the injection of the water and oil phases.
Several types of lipids were used to form lipid bilayers,
namely phosphatidylcholines DOPC (1,2 Dioleoyl sn glycero 3
phosphocholine) and DPHPC (1,2 diphytanoyl sn glycero 3 phos
phocholine) and monoolein (2,3 Dihydroxypropyl oleate). When
mentioned in the text (section on FITC diffusion), a more complex
lipid composition was additionally used for mimicking the mem
brane composition of RBC, and inspired from a reported composi
tion [57]; it was composed of DOPC 29% sphingomyelin (SM) 25%
lysophosphatidylcholine (LPC) 1% phosphatidylserine (DOPS) 15%
phosphatidylinositol (PI) 0.5% phosphatidic acid (PA) 1%
phosphatidylethanolamine (DOPE) 28.5%. This lipid composition
will be referred to as “Red Blood Cell like” in the text.
All lipids used in this study were purchased at Avanti Polar Lipid
(USA).5.9. Formation of an unsupported lipid bilayer
A variant of the Droplet Interface Bilayer (DiB) technique was
used to produce a free standing lipid membrane in a microﬂuidic
chip [37,38]. Using a volume controlled system with syringe
pumps, two ﬁngers of an aqueous phase containing 100 mM NaCl
were injected face to face into microchannels with a cross
geometry which were previously ﬁlled with squalene as oily solu
tion containing the lipid continuous phase (monoolein or DOPC)
(Fig. 6a). After few seconds, the water oil interface of each ﬁnger
was covered with a monolayer of lipid molecules. Once two liquid
ﬁngers were brought in contact, the two lipid monolayers interact
and form a lipid bilayer within a short time. This process is not
instant; it occurs by the drainage of the oil present between the two
lipid monolayers, during the so called zipping process. After its
formation, the bilayer is stable and can be analyzed simultaneously
by optical microscopy and electrophysiological experiments.5.10. Two droplets system to monitor Eu doped apatite NP or FITC
diffusion via epiﬂuorescence microscopy
Investigation of Eu doped apatite NP or of FITC diffusion
through model membranes was performed using a novel “two
droplets” system. The system is composed of two droplets sepa
rated by a lipid bilayer (monoolein or DOPC or asymmetric DOPC/
DPHPC). One droplet is typically composed of a medium (either
Apa6.5 or Apa6.5) containing the NP (0.1 ng/mL to 1 mg/mL) and
FITC (2 mM) when mentioned in the text, while the second droplet
is composed of the same medium but without NP nor FITC. By
observing both droplets by epiﬂuorescence microscopy we could
investigate the possible transfer of Eu doped apatite NP or FITC
through the lipid bilayer.
5.11. Electrophysiological measurements of the lipid membrane
The electrophysiological properties of the bilayer were analyzed
using a patch clamp ampliﬁer (EPC 10 USB HEKA). Ag/AgCl elec
trodes were prepared by inserting a silver chloride wire in a bo
rosilicate glass pipette (outer diameter 1.5 mm, inner diameter
0.86 mm, VWR) containing an electrolyte agarose solution. Lipid
membrane capacitance was measured using the Lock In function
provided by the patch clamp ampliﬁer.
5.12. Imaging of ﬂuorescent apatite NP and FITC
Epiﬂuorescence microscopy was used to detect the ﬂuorescence
signal emitted from the Eu doped apatite NP or from FITC. To this
aim, a commercial particle image velocimetry setup from LaVision
(Germany) was used which is based on an inverted epiﬂuorescence
microscope (Zeiss Axio Observer Z1). Eu doped NP were observed
under UV illumination at 256 nm (Newport, USA), and FITC mole
cules were followed under blue laser (473 nm) illumination.
5.13. Computational modeling of the NP/bilayer interaction
The interaction between the surface of a typical lipid bilayer and
one apatite nanoparticle was investigated using the Single Chain
Mean Field (SCMF) theory, described previously in the literature
[42,43]. In a 3 beads model, the lipid bilayer is then represented by
the ﬁelds of lipid tails (T) and heads (H), which can rearrange due to
local environment and interactions with external objects. In a
simpliﬁed approach, the apatite NP considered spherical was
modeled as adsorbing to lipid heads (H) through the negative
interaction parameter εH, this parameter characterizing the
attraction of lipid heads H to the NP. In these simulations, the fully
parametrized DMPC lipid composition was selected. Results can
however be extended to other lipid compositions (like DOPC for
instance) since the 3 beads model is a coarse grained model and
does not allow distinguishing behavioral differences at the
nanoscale.
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